Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia

Molecular Therapy

Volumn 5, Issue 4, 2002, Pages 352-359

  Eisterer, Wolfgang ^a   Jiang, Xiaoyan ^a   Bachelot, Thomas ^b   Pawliuk, Robert ^b   Abramovich, Carolina ^a   Leboulch, Philippe ^b,c,d   Hogge, Donna ^a,e   Eaves, Connie ^a,e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Genetix Pharmaceuticals Inc   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ALL; Angiogenesis; Gene therapy; Gene transfer; Immunodeficient mice

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CANCER CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MODEL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG POTENCY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC CODE; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RETROVIRUS; SCID MOUSE; TUMOR GROWTH; XENOTRANSPLANTATION;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0036222328     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0573     Document Type: Article

References (44)

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
2. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
3. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
4. Evidence of increased angiogenesis in patients with acute myeloid leukemia
5. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
6. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
7. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
8. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
9. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
10. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma
11. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors
12. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth
13. Reality testing in cancer treatment: The phase I trial of endostatin
14. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
15. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
16. Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth
17. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
18. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
19. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
20. Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach
21. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
22. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice
23. Mouse endostatin inhibits the formation of lung and liver metastases
24. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
25. Local endostatin treatment of gliomas administered by microencapsulated producer cells
26. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice
27. Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model
28. Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells
29. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice
30. A role for DNA-PK in retroviral DNA integration
31. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo
32. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
33. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lympho-myeloid differentiation in long-term marrow "switch" cultures
34. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice
35. Normal and leukemic human stem cells assayed in SCID mice
36. Biotherapy of xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-poke-weed anti-viral protein immunotoxin
37. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
38. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
39. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
40. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts
41. Construction and use of a safe and efficient amphotrophic packaging cell line
42. High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range
43. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
44. High-efficiency retroviral transduction of mammalian cells on positively charged surfaces